E-mail

E-mail a Wiley Online Library Link

David M. Hyman, Qin Zhou, Alexia Iasonos, Rachel N. Grisham, Angela G. Arnold, Mary F. Phillips, Jasmine Bhatia, Douglas A. Levine, Carol Aghajanian, Kenneth Offit, Richard R. Barakat, David R. Spriggs and Noah D. Kauff Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer Cancer 118

Version of Record online: 2 DEC 2011 | DOI: 10.1002/cncr.26655

Breast cancer gene 2 (BRCA2) mutations confer an overall survival advantage compared with both being BRCA-negative or having a BRCA1 mutation in high-grade serous ovarian cancer. This finding may have important implications for clinical trial design.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH